Home › Funds › MPM BioImpact LLC › TARS

MPM BioImpact LLC position in TARS

TARSUS PHARMACEUTICALS INC · Health Care

MPM BioImpact LLC reported holding 322,007 shares of TARS (TARSUS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$20.3M, representing 1.24% of its reported portfolio and ranking #31 among its reported holdings. MPM BioImpact LLC has disclosed TARS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)322.01K sh
Reported value held$20.27M
Portfolio Weight1.24%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's TARS position evolved

MPM BioImpact LLC first disclosed a stake in TARS in Q2 2025 at 341,496 shares (US$13.8M). The position peaked in Q4 2025 at 328,869 shares, worth US$26.9M. Across 5 filings, MPM BioImpact LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 322,007 shares valued at US$20.3M — a reduction of -7,743 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2025 341.50K $13.83M New
Q3 2025 341.50K $20.30M Hold
Q4 2025 328.87K $26.93M Reduce
Q1 2026 329.75K $23.13M Hold
Q2 2026 322.01K $20.27M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TARS and 13F data

TARS (TARSUS PHARMACEUTICALS INC) is a Health Care company. 39 other funds we track also report a position in TARS — the largest reported positions include Deep Track Capital, LP (US$230.8M), RTW INVESTMENTS, LP (US$211.3M), Paradigm Biocapital Advisors LP (US$174.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TARS

All TARS fund holders →

FAQ

How long has MPM BioImpact LLC held TARS?

MPM BioImpact LLC has disclosed TARS holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is MPM BioImpact LLC's current position in TARS?

As of Q2 2026, MPM BioImpact LLC holds 322.01K shares of TARS (TARSUS PHARMACEUTICALS INC), valued at $20.27M, representing 1.24% of its reported portfolio and ranking #31.

Has MPM BioImpact LLC been buying or selling TARS?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in TARS. The position peaked in Q4 2025 at 328.87K shares.

Which other funds hold TARS?

Other major institutional holders of TARS include Deep Track Capital, LP, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.